Skip to content

Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals

Comparison of the Effects of Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals at Increased Cardiometabolic Risk

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03306056
Acronym
EKAM
Enrollment
100
Registered
2017-10-10
Start date
2017-11-01
Completion date
2020-09-30
Last updated
2018-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity, Metabolic Syndrome

Keywords

Exercise, Strength Training, Health Promotion, Inflammation, Body Composition

Brief summary

The main purpose of this study is to compare the effects of whole-body electromyostimulation versus a conventional low-volume strength-training program, each combined with an individualized, weight-reducing diet, on the cardiometabolic risk profile, muscle strength, body composition, inflammatory markers and subjective health outcomes in overweight individuals at increased cardiometabolic risk.

Interventions

OTHERControl

Individualized, weight-reducing nutritional therapy and counseling, during a study period of 12 weeks

OTHERStandard Strength Training

Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined with a standard strength training program: * 5 strength training exercises (chest, upper/lower back, abdominals, legs) * 3 sets per exercise * time-effort per session: \ 90 min * 2 training sessions per week * duration of exercise intervention: 12 weeks

OTHERLow-volume Strength Training

Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined a low-volume strength training program: * 5 strength training exercises (chest, upper/lower back, abdominals, legs) * 1 set per exercise * time-effort per session: \ 20 min * 2 training sessions per week * duration of exercise intervention: 12 weeks

Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined with WB-EMS: * time-effort per session: \ 20 min * duration of exercise intervention: 12 weeks

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).

Intervention model description

parallel-group, randomized-controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body Mass Index \>25 * presence of at least 2 cardiometabolic risk factors

Exclusion criteria

* Healthy persons or patients under age * Overweight persons without any additional cardiometabolic risk factors * Pregnancy, Lactation * Psychological disorders, epilepsy, sever neurological disorders * Participation in other exercise- or nutrition studies within the last 6 months * acute cardiovascular disease * malignant disease * Rheuma * Intake of anabolic drugs, * Skin injuries in the area of electrode placements * Electronic implants (defibrillator, pacemaker) * Persons in mental hospitals by order of authorities or jurisdiction

Design outcomes

Primary

MeasureTime frameDescription
Metabolic Syndrome Z-Score (MetS-Z-Score)12 weeks (baseline to 12 week follow-up assessment)MetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.

Secondary

MeasureTime frameDescription
Body Composition12 weeks (baseline to 12 week follow-up assessment)Muscle mass, fat mass and body water will be measured by Bioelectrical Impedance Analysis (BIA)
Cardiorespiratory Fitness (CRF)12 weeks (baseline to 12 week follow-up assessment)CRF will be assessed by measuring Maximum Oxygen uptake (VO2max)
Inflammation status12 weeks (baseline to 12 week follow-up assessment)Inflammation will be assessed by measuring Levels of CRP and inflammatory cytokines and other inflammatory blood markers
Muscle strength12 weeks (baseline to 12 week follow-up assessment)Muscle strength of the five major muscle groups (chest, upper back, lower back, abdominals, legs) will be assessed by using specific strength-training devices (Butterfly, Pull-down, Hyperextension, Abdominal Crunch, Leg-Press)
Pain scores12 weeks (baseline to 12 week follow-up assessment)Pain scores will be assessed by using the standardized and validated Chronic Pain Grade Questionnaire (CPGQ)
Perceived stress12 weeks (baseline to 12 week follow-up assessment)Perceived stress will be assessed by using the standardized and validated Perceived Stress Questionnaire (PSQ)
Subjective work ability12 weeks (baseline to 12 week follow-up assessment)Subjective work ability will be assessed by using the standardized and validated Work Ability Index Questionnaire (WAI)
Health-related quality of life12 weeks (baseline to 12 week follow-up assessment)Health-related quality of life will be assessed by using the standardized and validated EQ-5D-5L Questionnaire

Countries

Germany

Contacts

Primary ContactDejan Reljic, Dr.
dejan.reljic@uk-erlangen.de+49 9131 8545218
Backup ContactYurdaguel Zopf, Prof.
yurdaguel.zopf@uk-erlangen.de+49 9131 8545218

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026